Information Provided By: 
Fly News Breaks for April 7, 2017
NVO
Apr 7, 2017 | 05:43 EDT
HSBC analyst Steve McGarry downgraded Novo Nordisk to Reduce to reflect lackluster news flow, valuation risk, and a sector backdrop where US pricing pressure could intensify.
News For NVO From the Last 2 Days
NVO
Apr 24, 2024 | 15:59 EDT
Senator Bernie Sanders is set to lead a Senate investigation into the high prices charged by Novo Nordisk for its diabetes and anti-obesity medications Ozempic and Wegovy, The Financial Times' Oliver Barnes reports. Sanders wrote to Novo Nordisk CEO Lars Fruergaard Jorgensen to inform him the U.S. committee that oversees healthcare is probing "the outrageously high prices" the company charges for the drugs, saying that the drugs "will not do any good for the millions of patients who cannot afford them." Reference Link
